Cytek Biosciences (CTKB) Enterprise Value (2020 - 2026)
Cytek Biosciences (CTKB) posted Enterprise Value of -$65.7 million for Q1 2026, up 27.69% on a QoQ basis from -$90.9 million in Q4 2025, and up 31.06% year-over-year from -$50.1 million in Q1 2025.
Cytek Biosciences (CTKB) Enterprise Value (2020 - 2026) Analysis & Trends
Cytek Biosciences' Enterprise Value history runs 7 years deep, the most recent figure standing at -$65.7 million for Q1 2026.
- Quarterly Enterprise Value rose 31.06% year-over-year to -$65.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$65.7 million (up 31.06% YoY) and the FY2025 annual result came in at -$90.9 million, up 7.99% from the prior year.
- Enterprise Value was -$65.7 million for Q1 2026 at Cytek Biosciences, up from -$90.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$65.7 million in Q1 2026 and bottomed at -$362.5 million in Q1 2022.
- A 5-year average of -$173.7 million and a median of -$162.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 112.28% — and 2023, when it soared 63.48%.
- Cytek Biosciences' Enterprise Value stood at -$299.5 million in 2022, then soared by 44.03% to -$167.6 million in 2023, then surged by 41.09% to -$98.7 million in 2024, then climbed by 7.99% to -$90.9 million in 2025, then advanced by 27.69% to -$65.7 million in 2026.
- Business Quant data shows CTKB's Enterprise Value at -$65.7 million in Q1 2026, -$90.9 million in Q4 2025, and -$93.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | -65.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.70 Mn |
| Dec 31, 2025 | -90.85 Mn |
| Sep 30, 2025 | -93.28 Mn |
| Jun 30, 2025 | -75.47 Mn |
| Mar 31, 2025 | -95.30 Mn |
| Dec 31, 2024 | -98.75 Mn |
| Sep 30, 2024 | -162.30 Mn |
| Jun 30, 2024 | -177.92 Mn |
| Mar 31, 2024 | -169.19 Mn |
| Dec 31, 2023 | -167.63 Mn |
| Sep 30, 2023 | -163.63 Mn |
| Jun 30, 2023 | -131.50 Mn |
| Mar 31, 2023 | -132.39 Mn |
| Dec 31, 2022 | -299.50 Mn |
| Sep 30, 2022 | -328.60 Mn |
| Jun 30, 2022 | -339.22 Mn |
| Mar 31, 2022 | -362.50 Mn |
| Dec 31, 2021 | -364.60 Mn |
| Sep 30, 2021 | -361.03 Mn |
| Jun 30, 2021 | -159.80 Mn |